Baranova, M. M., Muravyeva, N. V., Belov, B. S., Diatroptov, M. E., & Bukhanova, D. V. (2024). Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy. LLC "Publishing House OKI".
Chicago Style (17th ed.) CitationBaranova, M. M., N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, and D. V. Bukhanova. Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy. LLC "Publishing House OKI", 2024.
MLA citiranjeBaranova, M. M., et al. Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy. LLC "Publishing House OKI", 2024.